Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study
ConclusionTα1 use in COVID-19 patients was associated with an increased non-recovery rate, especially in those with greater disease severity.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | China Health | COVID-19 | Intensive Care | Respiratory Medicine | Study | Urology & Nephrology